ASX - By Stock
|
ADN |
Re:
Ann: Appendix 2A - Exercise of Options
|
|
arsenal54
|
16 |
5.8K |
6 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
16
|
5.8K
|
6
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Appendix 2A - Exercise of Options
|
|
arsenal54
|
16 |
5.8K |
21 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
16
|
5.8K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 2A
|
|
arsenal54
|
16 |
8.0K |
1 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
16
|
8.0K
|
1
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Pre-Feasibility Study Further Improves Poochera Economics
|
|
arsenal54
|
384 |
149K |
6 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
384
|
149K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - Most exciting 6 months
|
|
arsenal54
|
729 |
373K |
5 |
31/05/20 |
31/05/20 |
ASX - By Stock
|
729
|
373K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Trading Halt
|
|
arsenal54
|
159 |
88K |
12 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
159
|
88K
|
12
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Nova Secures Prepayment Funding Facility
|
|
arsenal54
|
111 |
33K |
2 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
111
|
33K
|
2
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Nova Secures Prepayment Funding Facility
|
|
arsenal54
|
111 |
33K |
7 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
111
|
33K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
arsenal54
|
17K |
6.7M |
6 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
arsenal54
|
17K |
6.7M |
14 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Will MSB become an ASX 200 company?
|
|
arsenal54
|
21 |
9.9K |
12 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
21
|
9.9K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Will MSB become an ASX 200 company?
|
|
arsenal54
|
21 |
9.9K |
7 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
21
|
9.9K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
arsenal54
|
17K |
6.7M |
10 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Trading Halt
|
|
arsenal54
|
106 |
31K |
21 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
106
|
31K
|
21
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Appendix 2A
|
|
arsenal54
|
2 |
1.8K |
10 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
2
|
1.8K
|
10
|
|
ASX - By Stock
|
NVA |
Re:
NVA - GOLD DISTRICT IN THE MAKING
|
|
arsenal54
|
686 |
240K |
1 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
686
|
240K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
arsenal54
|
188 |
78K |
4 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
188
|
78K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
arsenal54
|
449 |
189K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
449
|
189K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Competition? What Competition?
|
|
arsenal54
|
73 |
32K |
13 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
73
|
32K
|
13
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Drilling underway at Condooringie Halloysite-Kaolin Prospect
|
|
arsenal54
|
11 |
8.9K |
11 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
11
|
8.9K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
mesoblast looking forward
|
|
arsenal54
|
2 |
1.5K |
5 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
2
|
1.5K
|
5
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Nova Moves to 85% Ownership of the Estelle Gold Camp JV
|
|
arsenal54
|
61 |
20K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
61
|
20K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
arsenal54
|
23K |
13M |
16 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
23K
|
13M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Tracking Valuations
|
|
arsenal54
|
322 |
170K |
5 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
322
|
170K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
arsenal54
|
23K |
13M |
2 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
arsenal54
|
296 |
99K |
12 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
296
|
99K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
arsenal54
|
296 |
99K |
3 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
296
|
99K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Confirmation Bias
|
|
arsenal54
|
152 |
52K |
15 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
152
|
52K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
arsenal54
|
296 |
99K |
6 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
296
|
99K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Alan Kohler Interviews SI
|
|
arsenal54
|
38 |
15K |
17 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
38
|
15K
|
17
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Estelle Gold Exploration and Drilling Update
|
|
arsenal54
|
78 |
28K |
24 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
78
|
28K
|
24
|
|
ASX - By Stock
|
ADN |
Re:
ADNOB options - $0.012 strike, 30 November 2020 expiry
|
|
arsenal54
|
505 |
886K |
0 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
505
|
886K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
Newsflow Timeline
|
|
arsenal54
|
28 |
14K |
0 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
28
|
14K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Significant Kaolin Intersected at Mount Hope Project
|
|
arsenal54
|
37 |
24K |
33 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
37
|
24K
|
33
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Change in substantial holding - Buratu
|
|
arsenal54
|
19 |
9.1K |
7 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
19
|
9.1K
|
7
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
0 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
43K
|
20M
|
0
|
|
ASX - By Stock
|
ADN |
Re:
Countdown to Optimised Scoping Study
|
|
arsenal54
|
302 |
633K |
12 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
302
|
633K
|
12
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Strategic Investment and Estelle Gold COVID-19 Update
|
|
arsenal54
|
100 |
38K |
5 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
100
|
38K
|
5
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Strategic Investment and Estelle Gold COVID-19 Update
|
|
arsenal54
|
100 |
38K |
4 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
100
|
38K
|
4
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Strategic Investment and Estelle Gold COVID-19 Update
|
|
arsenal54
|
100 |
38K |
16 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
100
|
38K
|
16
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
1 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
43K
|
20M
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
11 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
43K
|
20M
|
11
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
1 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
43K
|
20M
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
5 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
43K
|
20M
|
5
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Video interview with Managing Director
|
|
arsenal54
|
73 |
33K |
3 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
73
|
33K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Video interview with Managing Director
|
|
arsenal54
|
73 |
33K |
8 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
73
|
33K
|
8
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Half Year Accounts 2019/20
|
|
arsenal54
|
9 |
4.3K |
28 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
9
|
4.3K
|
28
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
arsenal54
|
43K |
20M |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
43K
|
20M
|
1
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
arsenal54
|
12 |
36K |
9 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
12
|
36K
|
9
|
|
Charts
|
RAC |
Re:
RAC Charts
|
|
arsenal54
|
1.7K |
979K |
11 |
13/01/20 |
13/01/20 |
Charts
|
1.7K
|
979K
|
11
|
|